VolitionRx Ltd Quarterly report pursuant to Section 13 or 15(d)

StockBased Compensation (Details) - Warrants [Member]	9 Months Ended
StockBased Compensation (Details) - Warrants [Member]	Sep. 30, 2023 $ / shares shares
Number of warrants Outstanding beginning balance \| shares	539,000
Number of warrants Granted \| shares	448,500
Number of warrants Expired/Cancelled \| shares	125,000
Number of warrants outstanding ending balance \| shares	862,500
Number of Warrants Exercisable \| shares	387,000
Weighted Average Exercise Price Outstanding balance \| $ / shares	$ 3.80
Weighted Exercise Price Granted \| $ / shares	2.00
Weighted Exercise Price Expired/Cancelled \| $ / shares	2.47
Weighted Average Exercise Price ending balance \| $ / shares	3.05
Weighted Average Exercise Price exercisable \| $ / shares	$ 4.28